182 related articles for article (PubMed ID: 14605324)
1. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.
Di Napoli M; Papa F
Stroke; 2003 Dec; 34(12):2922-9. PubMed ID: 14605324
[TBL] [Abstract][Full Text] [Related]
2. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
Di Napoli M; Papa F;
Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349
[TBL] [Abstract][Full Text] [Related]
3. Association between blood pressure and C-reactive protein levels in acute ischemic stroke.
Di Napoli M; Papa F
Hypertension; 2003 Dec; 42(6):1117-23. PubMed ID: 14597640
[TBL] [Abstract][Full Text] [Related]
4. Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS.
Kitagawa K; Hosomi N; Nagai Y; Kagimura T; Ohtsuki T; Origasa H; Minematsu K; Uchiyama S; Nakamura M; Matsumoto M;
J Atheroscler Thromb; 2017 Oct; 24(10):1039-1047. PubMed ID: 28302952
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.
Winbeck K; Poppert H; Etgen T; Conrad B; Sander D
Stroke; 2002 Oct; 33(10):2459-64. PubMed ID: 12364738
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.
Tanne D; Benderly M; Goldbourt U; Haim M; Tenenbaum A; Fisman EZ; Matas Z; Adler Y; Zimmlichman R; Behar S
Stroke; 2006 Jul; 37(7):1720-4. PubMed ID: 16741173
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein in ischemic stroke: an independent prognostic factor.
Di Napoli M; Papa F; Bocola V
Stroke; 2001 Apr; 32(4):917-24. PubMed ID: 11283392
[TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D
Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease.
Arenillas JF; Alvarez-Sabín J; Molina CA; Chacón P; Montaner J; Rovira A; Ibarra B; Quintana M
Stroke; 2003 Oct; 34(10):2463-8. PubMed ID: 14500938
[TBL] [Abstract][Full Text] [Related]
11. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG
Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550
[TBL] [Abstract][Full Text] [Related]
12. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
Hypertension; 2005 Jan; 45(1):69-74. PubMed ID: 15569851
[TBL] [Abstract][Full Text] [Related]
13. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.
Di Napoli M; Papa F; Bocola V
Stroke; 2001 Jan; 32(1):133-8. PubMed ID: 11136928
[TBL] [Abstract][Full Text] [Related]
14. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.
Idicula TT; Brogger J; Naess H; Waje-Andreassen U; Thomassen L
BMC Neurol; 2009 Apr; 9():18. PubMed ID: 19400931
[TBL] [Abstract][Full Text] [Related]
15. Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study.
Yan H; Yan Z; Niu X; Wang J; Gui Y; Zhang P
Neurol Res; 2017 Apr; 39(4):337-343. PubMed ID: 28145815
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma YKL-40 levels and ischemic stroke in the general population.
Kjaergaard AD; Bojesen SE; Johansen JS; Nordestgaard BG
Ann Neurol; 2010 Nov; 68(5):672-80. PubMed ID: 21031582
[TBL] [Abstract][Full Text] [Related]
17. Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.
Ryu WS; Kim CK; Kim BJ; Kim C; Lee SH; Yoon BW
Atherosclerosis; 2012 Feb; 220(2):581-6. PubMed ID: 22178425
[TBL] [Abstract][Full Text] [Related]
18. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.
Ohkubo T; Chapman N; Neal B; Woodward M; Omae T; Chalmers J;
Am J Respir Crit Care Med; 2004 May; 169(9):1041-5. PubMed ID: 14990394
[TBL] [Abstract][Full Text] [Related]
19. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity.
Selim M; Savitz S; Linfante I; Caplan L; Schlaug G
BMC Neurol; 2005 Jun; 5(1):10. PubMed ID: 15949043
[TBL] [Abstract][Full Text] [Related]
20. Serum angiotensin-converting enzyme and recurrent vascular events. The SMART-MR study.
Jochemsen HM; Geerlings MI; Visseren FL; Algra A; van der Graaf Y; Muller M;
Atherosclerosis; 2012 Oct; 224(2):486-91. PubMed ID: 22884917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
